Are DRTSW insiders buying or selling?

In the last 90 days, Alpha (DRTSW) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own DRTSW?

See every hedge fund and asset manager holding Alpha (DRTSW).

How much of DRTSW trades in dark pools?

Track Alpha (DRTSW) dark pool activity and off-exchange block trades.

Alpha (DRTSW) — 86.8% Short — Squeeze Watch

Also trades as: DRTS (NASDAQ) · $vol 4M

$2.55

-0.42 (-14.14%)

Weekly Expected Move ±28.5%

$1 $2 $3 $4 $5

NASDAQ · Healthcare · Medical - Specialties · Alpha Radar Neutral · Power 58 · $905.4M mcap · 62M float · 0.114% daily turnover · Short 85% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Smart Money Score

No convergence signal

Key Statistics

Market Cap$905.4M

52W Range0.3251-3.11

Volume42,973

Avg Volume70,413

Beta1.17

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOUzi Sofer

Employees121

SectorHealthcare

IndustryMedical - Specialties

IPO Date2026-03-06

Websitealphatau.com

Kiryat HaMada St. 5
Jerusalem, JM 9777605
IL

972 3 577 4115

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Latest News